STELLA PHARMA CORPORATION

4888

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2027 Q1

Revenue

3.2100M JPY

YoY -67.4%

Operating Income

-2.5100M JPY

YoY -61.4%

Net Income

-8.5100M JPY

YoY -528.5%

EPS

-6.5JPY

YoY -42.4%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

9.6億円

5.2億円

77.1百万円

-3.6億円

-8.1億円

Rev: 1億円Op: -7.4億円NI: -7.7億円

Rev: 2.3億円Op: -8.1億円NI: -7.8億円

Rev: 2.7億円Op: -7.6億円NI: -7.6億円

Rev: 9.6億円Op: -90.2百万円NI: -1.4億円

Rev: 3.2億円Op: -7.5億円NI: -7.8億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress92M

Revenue Forecast10.400M

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan